The Department of Disease Control (DDC) has announced that Thailand is expecting human trials for a coronavirus vaccine to begin within four months.
The initial trial for the vaccine is expected to involve more than 10,000 participants after an agreement was made between the Ministry of Public Health and Chinese pharmaceutical companies.
Candidates for the initial trials will be carefully selected based on a broad range of criteria that is yet to be finalized.
In terms of the technology required to make the vaccine, the DDC is hoping for cooperation from China in providing the necessary technologies to assist Thai researchers in creating a vaccine as soon as possible.
When a vaccine is developed, there is a plan to give it to young people aged 29 to 39-years-old first due to the high number of infections in that age group.
Other high-risk groups will receive the vaccine next along with people who live in highly-populated areas.
The government has approved a 45 billion baht budget to fight the coronavirus which includes the development of a vaccine as the top priority.
Source: Bangkok Post